1) Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull 2001;27:235-245.
3) Jang OJ, Lee BD, Chung YI. A Study on Factors Related to Long-term Hospitalization in Patients with Chronic Schizophrenia. J Korean Neuropsychiatr Assoc 2015;54:76-83.
4) Allardyce J, Boydell J. Review: the wider social environment and schizophrenia. Schizophr Bull 2006;32:592-598.
6) Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Schizophrenia Patient Outcomes Research T. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull 2010;36:94-103.
7) Ahn JS, Lee YD, Bang HS, Park JE, Shin JH. Efforts and Therapeutic Factors of Short-term Token Economy for Negative Symptoms of Schizophrenic In-patients. J Korean Neuropsychiatr Assoc 1997;36:794-803.
8) Dickerson FB, Tenhula WN, Green-Paden LD. The token economy for schizophrenia: review of the literature and recommendations for future research. Schizophr Res 2005;75:405-416.
9) Kim YM, Cho BM, Jang KY, Chung YI. A survey on the Long-term Hospitalized, Chronically Mentally-ill Patients in Mental Health Facilities. J Korean Neuropsychiatr Assoc 1999;38:774-783.
10) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder: DSM-5. Washington, DC: American Psychiatric Association; 2013.
11) Gardner DM, Murphy AL, O’Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry 2010;167:686-693.
13) Kim JH, Yim SJ, Min SK, Kim SE, Son SJ, Wild DJ, et al. The Korean version of 4th revision of schizophrenia quality of life scale: validation study and relationship with PANSS. J Korean Neuropsychiatr Assoc 2006;45:401-410.
14) Markova IS, Roberts KH, Gallagher C, Boos H, McKenna PJ, Berrios GE. Assessment of insight in psychosis: a re-standardization of a new scale. Psychiatry Res 2003;119:81-88.
15) Kim J, Yim S, Yoon H. Assessing the reliability and validity of the korean version of the revised insight scale for psychosis (KISP). Korean J Schizophr Res 2004;7:15-22.
16) Lee YM, Park IH, Koo MS, Ko SY, Kang HM, Song JE. The Reliability and Validity of the Korean Version of Apathy Evaluation Scale and its Application in Patients with Schizophrenia. Korean J Schizophr Res 2013;16:80-85.
17) Conley RR, Ascher-Svanum H, Zhu B, Faries DE, Kinon BJ. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res 2007;90:186-197.
19) Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the korean version of the positive and negative syndrome scale. J Korean Neuropsychiatr Assoc 2001;40:1090-1105.
20) Puspitosari WA, Wardaningsih S, Nanwani S. Improving the quality of life of people with schizophrenia through community based rehabilitation in Yogyakarta Province, Indonesia: A quasi experimental study. Asian J Psychiatr 2019;42:67-73.
21) Lysaker PH, Vohs J, Hillis JD, Kukla M, Popolo R, Salvatore G, et al. Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches. Expert Rev Neurother 2013;13:785-793.
22) Amador XF, Gorman JM. Psychopathologic domains and insight in schizophrenia. Psychiatr Clin North Am 1998;21:27-42.